WNT signaling pathway and its connection with metabolic disorders: The role of DVL-1 and WIF-1
- 作者: Snimshchikova I.A.1, Plotnikova M.O.1, Kulakova A.S.1, Yakushkina N.Y.1
-
隶属关系:
- Turgenev State University of Orel
- 期: 卷 27, 编号 3 (2024)
- 页面: 545-552
- 栏目: SHORT COMMUNICATIONS
- URL: https://journal-vniispk.ru/1028-7221/article/view/267522
- DOI: https://doi.org/10.46235/1028-7221-16930-WSP
- ID: 267522
如何引用文章
全文:
详细
Obesity has been a global health problem over the past decades. The search for new ways in the fight against overweight and obesity leads to a deeper understanding of the pathogenetic mechanisms underlying this condition, and with each new study, the understanding of the problem expands first of all from the immunological approach. Despite the active study of the WNT signaling system in recent years, the available literature contains a small number of studies devoted to determining the components of this signaling pathway in the blood serum of obese people, and virtually no studies on WIF-1 and DVL-1. Purpose of the work: to study DVL-1 and WIF-1 in the blood serum of overweight and obese individuals. Patients (n = 210, aged 19 to 65) were examined, divided into 4 groups: I – people with normal body weight, II – patients with excess body weight; III – patients with metabolically healthy obesity, and IV – patients with metabolically unhealthy obesity using general clinical and immunological research methods. The study obtained data on the concentrations of DVL-1 and WIF-1 in the blood serum of patients with overweight, metabolically healthy and unhealthy obesity, and described the correlation between these proteins of the WNT-signaling pathway and clinical and laboratory parameters. In obese patients, statistically significant changes in the values of the components of the WNT signaling system in the blood serum were detected: an increase in the level of DVL-1, as well as an increase in the level of WIF-1 with an increase in the degree of obesity in metabolically healthy individuals. Correlations between DVL-1 and lipid spectrum indicators; between WIF- 1 with cholesterol profile, leukocytes and erythrocyte sedimentation rate were revealed. The pathogenesis of obesity is a complex process in which various immunopathological mechanisms, where the WNT signaling pathway plays one of the leading roles. Although some of the effects mediated by DVL-1 and WIF-1 have recently been elucidated, the details of their integration are a missing link that must be further explored for better understanding of the immunopathogenesis of metainflammation in obesity.
作者简介
I. Snimshchikova
Turgenev State University of Orel
编辑信件的主要联系方式.
Email: snimshikova@mail.ru
PhD, MD (Medicine), Professor, Head, Department of Immunology and Specialized Clinical Disciplines, Director
俄罗斯联邦, OrelM. Plotnikova
Turgenev State University of Orel
Email: snimshikova@mail.ru
PhD (Medicine), Associate Professor, Department of Immunology and Specialized Clinical Disciplines
俄罗斯联邦, OrelA. Kulakova
Turgenev State University of Orel
Email: snimshikova@mail.ru
Assistant Professor, Department of Immunology and Specialized Clinical Disciplines
俄罗斯联邦, OrelN. Yakushkina
Turgenev State University of Orel
Email: snimshikova@mail.ru
Associate Professor, Department of Immunology and Specialized Clinical Disciplines
俄罗斯联邦, Orel参考
- Кулакова А.С., Снимщикова И.А., Плотникова М.О. Роль морфогенных белков WNT-сигнального пути (склеростина и -катенина) в адипогенезе // Российский иммунологический журнал, 2020. Т. 23, № 2. C. 133-138. [Kulakova A.S., Snimshchikova I.A., Plotnikova M.O. Role of WNT signaling morphogenic proteins (sclerostin and -catenin) in adipogenesis. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2020, Vol. 23, no. 2, pp. 133-138. (In Russ.)] doi: 10.46235/1028-7221-326-ROW.
- Alsaedi M. The role of WNT inhibitory factor I in adipose tissue development. ETD Collection for Tennessee State University, 2016, AAI10158616. Available at: https://digitalscholarship.tnstate.edu/dissertations/AAI10158616.
- Brandão I., Martins M.J., Monteiro R. Metabolically healthy obesity-heterogeneity in definitions and unconventional factors. Metabolites, 2020, Vol. 10, no. 2, 48. doi: 10.3390/metabo10020048.
- Chen N., Wang J. Wnt/-Catenin Signaling and Obesity. Front. Physiol., 2018, Vol. 9, 792. doi: 10.3389/fphys.2018.00792.
- Das B., Das M., Kalita A., Baro M. R. The role of Wnt pathway in obesity induced inflammation and diabetes: a review. J. Diabetes Metab. Disord., 2021, Vol. 20, no. 2, pp. 1871-1882.
- Elías-López D., Vargas-Vázquez A., Mehta, R., Cruz Bautista I., Del Razo Olvera F., Gómez-Velasco D., Almeda Valdes P., Aguilar-Salinas C.A. Metabolic Syndrome Study Group. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study. BMC Endocr. Disord., 2021, Vol. 21, no. 1, 85. doi: 10.1186/s12902-021-00754-1.
- Karczewska-Kupczewska M., Stefanowicz M., Matulewicz N., Nikołajuk A., Strączkowski M. Wnt signaling genes in adipose tissue and skeletal muscle of humans with different degrees of insulin sensitivity. J. Clin. Endocrinol. Metab., 2016, Vol. 101, no. 8, pp. 3079-3087.
- Liu J., Xiao Q., Xiao J., Niu C., Li Y., Zhang X., Zhou Z., Shu G., Yin G. Wnt/-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct. Target. Ther., 2022, Vol. 7, no. 1, 3. doi: 10.1038/s41392-021-00762-6.
- Louie S.H., Yang X.Y., Conrad W.H., Muster J., Angers S., Moon R.T., Cheyette B.N. Modulation of the beta-catenin signaling pathway by the dishevelled-associated protein Hipk1. PloS One, 2009, Vol. 4, no. 2, e4310. doi: 10.1371/journal.pone.0004310.
- Mani A., Radhakrishnan J., Wang H., Mani A., Mani M.A., Nelson-Williams C., Carew K.S., Mane S., Najmabadi H., Wu D., Lifton R.P. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science (New York, N.Y.), 2007, Vol. 315, no. 5816, pp. 1278-1282.
- Obesity and overweight, 2024, 1 March, Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
- Poggi L., Casarosa S., Carl M. An eye on the Wnt inhibitory gactor Wif1. Front. Cell Dev. Biol., 2018, Vol. 6, 167. doi: 10.3389/fcell.2018.00167.
- Sharma M., Castro-Piedras I., Simmons G.E. Jr, Pruitt K. Dishevelled: A masterful conductor of complex Wnt signals. Cell. Signal., 2018, Vol. 47, pp. 52-64.
- Tutor A.W., Lavie C.J., Kachur S., Milani R.V., Ventura H.O. Updates on obesity and the obesity paradox in cardiovascular diseases. Progr. Cardiovasc. Dis., 2023, Vol. 78, pp. 2-10.
- Začiragić A. The role of meta-inflammation in the adipose tissue dysfunction and obesity. Meta-Inflammation and Obesity, Bentham Science Publishers, 2020, pp. 63-80.
补充文件
